| Cardiomyopathy |
0 |
0.99 |
| Cardiovascular Imaging |
0 |
0.9 |
| Heart Failure (HF) |
0 |
0.78 |
| Heart |
0 |
0.72 |
| Ejection Fraction |
0 |
0.56 |
| Food and Drug Administration (FDA) |
0 |
0.98 |
| Hypertrophic Cardiomyopathy |
0 |
1 |
| Genetic Disorders |
0 |
0.17 |
| Genomic Medicine |
0 |
0.17 |
| Clinical Guidelines |
0 |
0.12 |
| Echocardiography |
0 |
0.12 |
| Exercise |
0 |
0.12 |
| Genetics |
0 |
0.12 |
| Indiana |
0 |
0.12 |
| New York |
0 |
0.12 |
| Pennsylvania |
0 |
0.12 |
| Risk Evaluation and Mitigation Strategies |
0 |
0.12 |
| Patient Safety |
0 |
0.1 |
| Revenue and Practice Management |
0 |
0.1 |